-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert H. Noth, MD

Articles by Robert H. Noth, MD

Prevalence of Osteoporosis in Men in a VA Rehabilitation Center

ByArthur Swislocki, MD,Jon A. Green, MD, PhD,Gerhard Heinrich, MD,Charles A. Barnett, MD,Ivan D. Meadows, MD,Ernest B. Harmon, BS,Mary F. Rank, RN, FNP,Robert H. Noth, MD

June 10th 2010

Men in a VA rehabilitation unit who had osteoporosis were older and thinner, but otherwise similar (metabolic and functional status) to control subjects.

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

ByJoy L. Meier, PharmD,Arthur L.M. Swislocki, MD,Julio R. Lopez, PharmD,Robert H. Noth, MD,Patricia Bartlebaugh, MSN,David Siegel, MD

June 1st 2002

Safety and Efficacy of Metformin in a Restricted Formulary

ByArthur L. M. Swislocki, MD,Quan Khuu,Ellen Liao,Emily Wu,Fil Beza,Julio Lopez, PharmD,Gene Kwan,Robert H. Noth, MD

January 1st 1999

Postmarketing Analysis of Lovastatin Use in the VA Northern California System of Clinics: A Retrospective, Computer-Based Study

ByArthur L. M. Swislocki, MD,Kim Lin,Diane Cogburn, PharmD,Karen Y. Fann,Duke T. Khuu,Robert H. Noth, MD

October 1st 1997

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention